Back to Search
Start Over
Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels
- Source :
- Endocrinology, Endocrinology, Vol. 153, No 3 (2012) pp. 1269-78
- Publication Year :
- 2012
-
Abstract
- Autoantibodies to apolipoprotein A-1 (antiapoA-1 IgG) have been shown to be associated with higher resting heart rate and morbidity in myocardial infarction patients and to behave as a chronotropic agent in the presence of aldosterone on isolated neonatal rat ventricular cardiomyocytes (NRVC). We aimed at identifying the pathways accounting for this aldosterone-dependent antiapoA-1 IgG-positive chronotropic effect on NRVC. The rate of regular spontaneous contractions was determined on NRVC in the presence of different steroid hormones and antagonists. AntiapoA-1 IgG chronotropic response was maximal within 20 min and observed only in aldosterone-pretreated cells but not in those exposed to other steroids. The positive antiapoA-1 IgG chronotropic effect was already significant after 5 min aldosterone preincubation, was dependent on 3-kinase and protein kinase A activities, was not inhibited by actinomycin D, and was fully abrogated by eplerenone (but not by spironolactone), demonstrating the dependence on a nongenomic action of aldosterone elicited through the mineralocorticoid receptor (MR). Under oxidative conditions (but not under normal redox state), corticosterone mimicked the permissive action of aldosterone on the antiapoA-1 IgG chronotropic response. Pharmacological and patch-clamp studies identified L-type calcium channels as crucial effectors of antiapoA-1 IgG chronotropic action, involving two converging pathways that increase the channel activity. The first one involves the rapid, nongenomic activation of the phosphatidylinositol 3-kinase enzyme by MR, and the second one requires a constitutive basal protein kinase A activity. In conclusion, our results indicate that, on NRVC, the aldosterone-dependent chronotropic effects of antiapoA-1 IgG involve the nongenomic activation of L-type calcium channels.
- Subjects :
- Chronotropic
Time Factors
030204 cardiovascular system & hematology
Spironolactone
chemistry.chemical_compound
Phosphatidylinositol 3-Kinases
0302 clinical medicine
Endocrinology
Mineralocorticoid receptor
Corticosterone
Receptors, Mineralocorticoid/metabolism
Myocytes, Cardiac
Aldosterone
Cells, Cultured
ddc:616
0303 health sciences
Voltage-dependent calcium channel
Dactinomycin/pharmacology
Myocytes, Cardiac/cytology
Eplerenone
Electrophysiology/methods
Electrophysiology
Immunoglobulin G/chemistry
Dactinomycin
Phosphatidylinositol 3-Kinases/metabolism
Oxidation-Reduction
medicine.drug
medicine.medical_specialty
Calcium Channels, L-Type
Oxygen/chemistry
03 medical and health sciences
Internal medicine
Aldosterone/metabolism
medicine
Animals
L-type calcium channel
Rats, Wistar
Spironolactone/analogs & derivatives/pharmacology
030304 developmental biology
Apolipoprotein A-I
Calcium Channels, L-Type/chemistry
Apolipoprotein A-I/chemistry
Rats
Oxygen
Receptors, Mineralocorticoid
chemistry
Animals, Newborn
Immunoglobulin G
Subjects
Details
- ISSN :
- 00137227
- Volume :
- 153
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Endocrinology
- Accession number :
- edsair.doi.dedup.....73b3ff21e285b00b5a52a7c57fc55f26
- Full Text :
- https://doi.org/10.1210/en.2011-1835